702 The microbiota regulates type 2 immunity through RORγt+ T cells.
http://www.sciencemag.org/content/349/6251/989.abstract
701 IgH sequences in common variable immune deficiency reveal altered B cell development and selection.
http://stm.sciencemag.org/content/7/302/302ra135
700 Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria.
http://www.nature.com/ncomms/2015/150827/ncomms9072/full/ncomms9072.html
699 A common glycan structure on immunoglobulin G for enhancement of effector functions.
http://www.pnas.org/content/112/34/10611.abstract
698 Sialic acid catabolism drives intestinal inflammation and microbial dysbiosis in mice.
http://www.nature.com/ncomms/2015/150825/ncomms9141/full/ncomms9141.html
697 Prophylactic and postexposure efficacy of a potent human monoclonal antibody against MERS coronavirus.
http://www.pnas.org/content/112/33/10473.abstract
696 A synthetic consensus anti–spike protein DNA vaccine induces protective immunity against Middle East respiratory syndrome coronavirus in nonhuman primates.
http://stm.sciencemag.org/content/7/301/301ra132
695 VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain.
http://www.sciencemag.org/content/349/6249/739.abstract
694 Efficacy of a virus-vectored vaccine against human and bovine respiratory syncytial virus infections.
http://stm.sciencemag.org/content/7/300/300ra127
693 Chimpanzee adenovirus– and MVA-vectored respiratory syncytial virus vaccine is safe and immunogenic in adults.
http://stm.sciencemag.org/content/7/300/300ra126
|
